The new technology, developed by Dr Gentile and his team, uses bioprinted ‘mini-hearts’ and ‘patches’ to repair areas of damaged tissue in a failing heart.
“My team has been researching the differences between a healthy and a damaged heart for over 15 years. These studies helped us to bioengineer mini-hearts that can prevent and treat cardiovascular disease, the leading cause of death worldwide.
“We believe our research could offer a real, long-term alternative to heart transplants for patients with heart failure.”
It truly is incredible technology, but we need your support to start human clinical trials.
“Our personalised bioprinted patches could significantly reduce risks, times and costs associated with a heart transplant. We’re working every day to refine our technology and make it available to cardiovascular patients.”
To make this research a reality, your support is vital. Will you donate to help develop new treatment for heart failure and other cardiovascular diseases?